Barinthus Biotherapeutics (BRNS) Analyst & Key Data

Analyst Consensus

Buy0 analysts

Buy

Updated Sep 12, 2026

Total Analysts0

Buy

3

Hold

1

Ratings

Updated Sep 12, 2026

Overall Rating

B

DCF Score5.0 / 5

Debt / Equity Score3.0 / 5

Price / Book Score5.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$0.74

Median Target-100.00%

$0.00

Potential downside vs current price

DCF Value+100.31%

$1.48

Potential upside vs current price

Current Stock Price

$0.74

Median Target-100.00%

$0.00

Potential downside vs current price

DCF Value+100.31%

$1.48

Potential upside vs current price

Analyst Consensus

Buy0 analysts

Buy

Updated Sep 12, 2026

Total Analysts0

Buy

3

Hold

1

Ratings

Updated Sep 12, 2026

Overall Rating

B

DCF Score5.0 / 5

Debt / Equity Score3.0 / 5

Price / Book Score5.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$0.74

Median Target-100.00%

$0.00

Potential downside vs current price

DCF Value+100.31%

$1.48

Potential upside vs current price

Current Stock Price

$0.74

Median Target-100.00%

$0.00

Potential downside vs current price

DCF Value+100.31%

$1.48

Potential upside vs current price

Barinthus Biotherapeutics plc